REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 31st, 2024 • TRxADE HEALTH, INC • Wholesale-drugs, proprietaries & druggists' sundries • Delaware
This Registration Rights Agreement (this “Agreement”) is dated as of ____________, 2024, by and among TRxADE Health, Inc., a Delaware corporation (the “Company”), and the several former stockholders of Scienture, Inc. signatory hereto (each, including its successors and assigns, a “Holder” and collectively, the “Holders”).
CONSULTING AGREEMENTConsulting Agreement • July 31st, 2024 • TRxADE HEALTH, INC • Wholesale-drugs, proprietaries & druggists' sundries • Delaware
This Consulting Agreement (this “Agreement”) is made and entered into as of this 25th day of July, 2024, between TRxADE HEALTH, INC., a Delaware corporation (as the name may be changed in accordance with the provisions of the DGCL, the “Company”) and Surendra K. Ajjarapu (“Consultant”). The Company and Consultant are referred to herein individually as a “Party,” or collectively as the “Parties.” The Executive Employment Agreement, dated April 14, 2020, as amended on May 5, 2020, August 29, 2022 and January 17, 2023, shall be terminated immediately upon the Service Start Date (as defined below) of this Agreement (the “Executive Employment Agreement”).
LOCK-UP AGREEMENTLock-Up Agreement • July 31st, 2024 • TRxADE HEALTH, INC • Wholesale-drugs, proprietaries & druggists' sundries • Delaware
THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of July 25, 2024, by and between (i) TRxADE HEALTH, INC., a Delaware corporation (including any successor entity thereto, “MEDS”), and (ii) ______________________ (the “Subject Party”). Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Merger Agreement (as defined below).
AGREEMENT AND PLAN OF MERGER among: TRXADE HEALTH, INC.; MEDS MERGER SUB I, INC.; MEDS MERGER SUB II, LLC; and SCIENTURE, INC. Dated as of July 25, 2024Merger Agreement • July 31st, 2024 • TRxADE HEALTH, INC • Wholesale-drugs, proprietaries & druggists' sundries • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 25, 2024, by and among TRxADE Health INC., a Delaware corporation (“MEDS”), MEDS MERGER SUB I, Inc., a Delaware corporation and wholly owned subsidiary of MEDS (“Merger Sub I”), MEDS MERGER SUB II, LLC, a Delaware limited liability company and wholly owned subsidiary of MEDS (“Merger Sub II” and together with Merger Sub I, “Merger Subs”), and Scienture, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1.
